Roche bets $555M on an Indian biotech’s immuno-oncology drug

Roche inked a deal worth up to $555 million to work with India’s Curadev Pharma on cancer treatments that use the body’s immune system to combat tumors, expanding its trove of assets in one of the industry’s hottest fields.

Source: www.fiercebiotech.com

---